SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer.
Cancer Res
; 77(11): 2990-3000, 2017 06 01.
Article
in En
| MEDLINE
| ID: mdl-28416483
Full text:
1
Database:
MEDLINE
Main subject:
Piperazines
/
Src-Family Kinases
/
Focal Adhesion Protein-Tyrosine Kinases
/
Lung Neoplasms
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Year:
2017
Type:
Article